Approach

Sense has adopted a distinctive approach which sets it apart from other diagnostics companies.

We believe that to allow the potential of point-of-care molecular diagnostics to be realised a new class of product is required that meets the real needs of frontline users.

Where competitors are repurposing existing technical solutions for use outside the laboratory Sense has developed new methods and approaches to realise simple, rapid, handheld tests with the power of advanced laboratory equipment.

 
allround.png
 

Technology

Sense products exploit a suite of proprietary molecular and device technologies developed specifically for integration into affordable, handheld tests.

Our molecular methods represent a simple and ultra-rapid alternative to polymerase chain reaction (PCR) and enable sensitive detection of specific nucleic acids without the need for complex hardware to perform temperature cycling and fluorescent detection.

Our device technologies include innovation in low-cost fluid handling, temperature control and mechanical design.

Sense technologies provide conclusive, clinically relevant information in just a few minutes enabling treatment decisions to be actioned immediately.

 
techa.png
 

Design

True Point-of-Care requires diagnostic tests to be performed by end-users, rather than laboratory scientists. This means understanding the needs of those users in detail to ensure they are met.

To achieve this we adopt a user-centred approach to design ensuring that simplicity and usability are fundamental to our thinking. This drives us to develop the technologies required to realise the best products rather than develop compromised products to suit the available technologies.

 
webprshot.jpg
 

Scalability

Sense develop platform technologies driven by a systematic approach to ensure our designs meet both user and market needs across a wide range of clinical applications.

Our extensive experience of development for high volume manufacture means that the processes we adopt drive down costs and reduce development risk across a whole range of applications meaning that scalability is built into our products from the outset.

 
2018 website - back shot.66.jpg